These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


184 related items for PubMed ID: 21206549

  • 1. The nightly use of sodium oxybate is associated with a reduction in nocturnal sleep disruption: a double-blind, placebo-controlled study in patients with narcolepsy.
    Black J, Pardi D, Hornfeldt CS, Inhaber N.
    J Clin Sleep Med; 2010 Dec 15; 6(6):596-602. PubMed ID: 21206549
    [Abstract] [Full Text] [Related]

  • 2. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.
    Black J, Pardi D, Hornfeldt CS, Inhaber N.
    Sleep Med; 2009 Sep 15; 10(8):829-35. PubMed ID: 19616998
    [Abstract] [Full Text] [Related]

  • 3. A pilot study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsy.
    Mamelak M, Black J, Montplaisir J, Ristanovic R.
    Sleep; 2004 Nov 01; 27(7):1327-34. PubMed ID: 15586785
    [Abstract] [Full Text] [Related]

  • 4. A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy.
    Xyrem International Study Group.
    J Clin Sleep Med; 2005 Oct 15; 1(4):391-7. PubMed ID: 17564408
    [Abstract] [Full Text] [Related]

  • 5. Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients.
    Xyrem International Study Group.
    Sleep Med; 2005 Sep 15; 6(5):415-21. PubMed ID: 16099718
    [Abstract] [Full Text] [Related]

  • 6. Effect of FT218, a Once-Nightly Sodium Oxybate Formulation, on Disrupted Nighttime Sleep in Patients with Narcolepsy: Results from the Randomized Phase III REST-ON Trial.
    Roth T, Dauvilliers Y, Thorpy MJ, Kushida C, Corser BC, Bogan R, Rosenberg R, Dubow J, Seiden D.
    CNS Drugs; 2022 Apr 15; 36(4):377-387. PubMed ID: 35380374
    [Abstract] [Full Text] [Related]

  • 7. A 12-month, open-label, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsy.
    Sleep; 2003 Feb 01; 26(1):31-5. PubMed ID: 12627729
    [Abstract] [Full Text] [Related]

  • 8. Once-nightly sodium oxybate (FT218) improved symptoms of disrupted nighttime sleep in people with narcolepsy: a plain language summary.
    Roth T, Thorpy MJ, Kushida CA, Horsnell M, Gudeman J.
    J Comp Eff Res; 2023 Dec 01; 12(12):e230133. PubMed ID: 37971303
    [Abstract] [Full Text] [Related]

  • 9. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy.
    Sleep; 2002 Feb 01; 25(1):42-9. PubMed ID: 11833860
    [Abstract] [Full Text] [Related]

  • 10. A randomized trial evaluating the effectiveness of sodium oxybate therapy on quality of life in narcolepsy.
    Weaver TE, Cuellar N.
    Sleep; 2006 Sep 01; 29(9):1189-94. PubMed ID: 17040006
    [Abstract] [Full Text] [Related]

  • 11. Changes in Cataplexy Frequency in a Clinical Trial of Lower-Sodium Oxybate with Taper and Discontinuation of Other Anticataplectic Medications.
    Dauvilliers Y, Šonka K, Bogan RK, Partinen M, Del Rio Villegas R, Foldvary-Schaefer N, Skowronski R, Chen A, Black J, Skobieranda F, Thorpy MJ.
    CNS Drugs; 2022 Jun 01; 36(6):633-647. PubMed ID: 35635687
    [Abstract] [Full Text] [Related]

  • 12. Sodium oxybate: new drug. Fewer attacks of cataplexy in some patients.
    Prescrire Int; 2007 Jun 01; 16(89):98-101. PubMed ID: 17582923
    [Abstract] [Full Text] [Related]

  • 13. Sodium oxybate in the treatment of childhood narcolepsy-cataplexy: a retrospective study.
    Mansukhani MP, Kotagal S.
    Sleep Med; 2012 Jun 01; 13(6):606-10. PubMed ID: 22445591
    [Abstract] [Full Text] [Related]

  • 14. Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy.
    Black J, Swick T, Bogan R, Lai C, Carter LP.
    Sleep Med; 2016 Aug 01; 24():57-62. PubMed ID: 27810187
    [Abstract] [Full Text] [Related]

  • 15. Sodium oxybate and sleep apnea: a clinical case.
    Hartley S, Quera-Salva MA, Machou M.
    J Clin Sleep Med; 2011 Dec 15; 7(6):667-8. PubMed ID: 22171208
    [Abstract] [Full Text] [Related]

  • 16. Long-term safety and maintenance of efficacy of sodium oxybate in the treatment of narcolepsy with cataplexy in pediatric patients.
    Lecendreux M, Plazzi G, Dauvilliers Y, Rosen CL, Ruoff C, Black J, Parvataneni R, Guinta D, Wang YG, Mignot E.
    J Clin Sleep Med; 2022 Sep 01; 18(9):2217-2227. PubMed ID: 35689598
    [Abstract] [Full Text] [Related]

  • 17. Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients with Narcolepsy: A Commentary.
    Rosenberg R, Braceras R, Macfadden W, Candler S, Black J, Ruoff C.
    Neurol Ther; 2023 Dec 01; 12(6):1805-1820. PubMed ID: 37755650
    [Abstract] [Full Text] [Related]

  • 18. Long-Term Safety and Tolerability During a Clinical Trial and Open-Label Extension of Low-Sodium Oxybate in Participants with Narcolepsy with Cataplexy.
    Bogan RK, Foldvary-Schaefer N, Skowronski R, Chen A, Thorpy MJ.
    CNS Drugs; 2023 Apr 01; 37(4):323-335. PubMed ID: 36947322
    [Abstract] [Full Text] [Related]

  • 19. Sodium oxybate improves excessive daytime sleepiness in narcolepsy.
    Black J, Houghton WC.
    Sleep; 2006 Jul 01; 29(7):939-46. PubMed ID: 16895262
    [Abstract] [Full Text] [Related]

  • 20. Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy.
    Kushida CA, Shapiro CM, Roth T, Thorpy MJ, Corser BC, Ajayi AO, Rosenberg R, Roy A, Seiden D, Dubow J, Dauvilliers Y.
    Sleep; 2022 Jun 13; 45(6):. PubMed ID: 34358324
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.